Added to YB: 2019-06-06
Pitch date: 2019-06-06
IMMU:US [bullish]
Immunomedics, Inc.
+594%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Immunomedics, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibody-based products to treat cancer.
Market Cap
$20.3B
Pitch Price
$12.66
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-51.59
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
IMMUNOMEDICS INC COM IMMU:US
A summary for this pitch has not been created yet.
Read full article (0 min)